Consistent with this, the present in vivo data indicated that ablating HIF-1α by silencing Notch1 as a guard-molecule or by treating with chetomin, a HIF pathway inhibitor, induced significant anti-tumor effects in GBM xenograft models. The gene discussed is NOTCH1; the disease is neoplasm.